Hiroji Iwata Selected Research

Segmental Mastectomy (Lumpectomy)

4/2023	Satisfaction survey on a preoperative explanation method using three-dimensional breast imaging for breast cancer patients considering breast-conserving surgery.
7/2020	Utility of regional nodal irradiation in Japanese patients with breast cancer with 1-3 positive nodes after breast-conserving surgery and axillary lymph-node dissection.
11/2018	A case of radiation-associated angiosarcoma after breast cancer.
9/2016	Impact of intraoperative specimen mammography on margins in breast-conserving surgery.
7/2014	Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review.
5/2014	Incidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapy.
3/2014	Detection of parasternal metastatic lymph nodes by sentinel lymph node methods in a patient with recurrence in the conserved breast.
1/2005	Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroji Iwata Research Topics

Disease

258	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2002
96	Neoplasms (Cancer) 04/2024 - 01/2002
28	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2002
24	Neutropenia 11/2023 - 08/2008
19	Triple Negative Breast Neoplasms 12/2023 - 12/2012
18	Disease Progression 04/2024 - 01/2007
7	Diarrhea 06/2023 - 12/2015
6	Carcinoma (Carcinomatosis) 01/2024 - 10/2002
6	Fatigue 10/2022 - 07/2015
6	Leukopenia 09/2021 - 08/2008
5	Vomiting 01/2021 - 10/2007
5	Nausea 01/2021 - 10/2007
5	Febrile Neutropenia 01/2020 - 10/2007
5	Brain Neoplasms (Brain Tumor) 11/2017 - 08/2013
4	Pathologic Complete Response 11/2023 - 04/2011
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 08/2020
4	Pneumonia (Pneumonitis) 01/2023 - 08/2020
4	Thrombocytopenia (Thrombopenia) 08/2022 - 01/2015
4	Anemia 01/2021 - 11/2014
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 04/2002
4	Stomatitis 12/2019 - 11/2014
4	Carcinogenesis 10/2019 - 02/2003
4	Hand-Foot Syndrome 11/2018 - 10/2010
4	Ductal Carcinoma 09/2018 - 06/2006
4	Edema (Dropsy) 03/2017 - 01/2005
3	Arthralgia (Joint Pain) 10/2023 - 01/2005
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2020
3	Lymphatic Metastasis 10/2021 - 11/2002
3	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2021 - 08/2017
3	Alopecia (Baldness) 11/2020 - 12/2015
3	Exanthema (Rash) 01/2019 - 01/2015
3	Hyperglycemia 01/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

65	Hormones (Hormone)IBA 04/2024 - 01/2002
42	Estrogen ReceptorsIBA 12/2023 - 10/2002
42	Trastuzumab (Herceptin)FDA Link 06/2023 - 10/2005
34	ErbB Receptors (EGF Receptor)IBA 01/2024 - 05/2011
24	human ERBB2 proteinIBA 12/2023 - 10/2008
22	palbociclibIBA 11/2023 - 07/2015
17	Aromatase InhibitorsIBA 03/2023 - 06/2010
17	Fulvestrant (Faslodex)FDA Link 01/2023 - 12/2013
16	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2009
14	Docetaxel (Taxotere)FDA Link 08/2021 - 01/2005
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 02/2004
11	Cyclin-Dependent Kinase 4IBA 10/2023 - 01/2017
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2007
11	exemestane (Aromasin)FDA Link 01/2023 - 04/2011
10	abemaciclibIBA 04/2024 - 01/2019
10	trastuzumab deruxtecanIBA 01/2024 - 01/2019
10	taxaneIBA 01/2023 - 11/2009
10	Capecitabine (Xeloda)FDA Link 11/2018 - 02/2004
10	Tamoxifen FDA LinkGeneric 12/2014 - 07/2003
9	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2015
9	Letrozole (Femara)FDA LinkGeneric 01/2023 - 04/2011
9	Progesterone Receptors (Progesterone Receptor)IBA 10/2021 - 07/2003
9	AnthracyclinesIBA 10/2020 - 11/2009
8	130-nm albumin-bound paclitaxelIBA 11/2021 - 05/2017
8	atezolizumabIBA 11/2021 - 11/2018
8	Phenobarbital (Luminal)FDA Link 09/2021 - 04/2011
8	Anastrozole (Arimidex)FDA LinkGeneric 11/2014 - 06/2010
7	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2007
7	Lapatinib (GW572016)FDA Link 08/2021 - 08/2013
7	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 01/2005
7	Epirubicin (Ellence)FDA LinkGeneric 04/2020 - 02/2004
6	pembrolizumabIBA 12/2023 - 12/2020
6	neratinibIBA 01/2023 - 03/2016
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 08/2013
6	pertuzumabIBA 09/2022 - 05/2018
5	LigandsIBA 05/2024 - 10/2020
5	Epidermal Growth Factor (EGF)IBA 04/2024 - 05/2010
5	EnzymesIBA 01/2023 - 04/2002
5	Bevacizumab (Avastin)FDA Link 06/2022 - 10/2011
5	B7-H1 AntigenIBA 01/2022 - 11/2018
5	Gemcitabine FDA Link 01/2022 - 11/2009
5	eribulin FDA Link 01/2018 - 06/2013
4	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2015
4	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2017
4	Albumin-Bound Paclitaxel FDA Link 01/2022 - 04/2015
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 06/2014
4	Monoclonal AntibodiesIBA 01/2020 - 10/2005
4	Everolimus FDA Link 10/2019 - 05/2013
4	ORALIT (ORS)IBA 02/2011 - 04/2002
3	Messenger RNA (mRNA)IBA 01/2023 - 06/2006
3	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2017
3	TeaIBA 01/2022 - 08/2021
3	Estrogens (Estrogen)FDA Link 10/2019 - 04/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2014
3	Goserelin (Zoladex)FDA Link 01/2017 - 04/2012
3	thiamine triphosphorate (TTP)IBA 03/2015 - 02/2010

Therapy/Procedure

119	Therapeutics 04/2024 - 07/2003
60	Drug Therapy (Chemotherapy) 03/2024 - 01/2005
23	Neoadjuvant Therapy 11/2023 - 01/2005
18	Adjuvant Chemotherapy 06/2023 - 10/2005
15	Radiotherapy 04/2024 - 09/2007
8	Segmental Mastectomy (Lumpectomy) 04/2023 - 01/2005
7	Lymph Node Excision (Lymph Node Dissection) 07/2020 - 11/2002
6	Mastectomy (Mammectomy) 12/2023 - 09/2018
5	Mammaplasty (Breast Reconstruction) 10/2023 - 09/2018
4	Drug Tapering 08/2022 - 10/2016
3	Operative Surgical Procedures 05/2019 - 05/2017
3	Duration of Therapy 01/2019 - 01/2007